We came across a bullish thesis on Vericel Corporation on R.Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on VCEL. Vericel Corporation's share was trading at $36.26 as of July 17th. VCEL’s trailing and forward P/E were 742.40 and 416.67, respectively according to Yahoo Finance.
Vericel Corporation (VCEL) stands at a pivotal inflection point as a newly profitable, high-growth leader in the niche regenerative medicine markets of sports medicine and severe burn care. Having transitioned from a speculative, cash-burning biotech to a disciplined,...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.